Gates Medical Research Institute
Clinical trials sponsored by Gates Medical Research Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New TB combo drug trial aims to shorten treatment Results expected Nov 2026 (estimated)
-
Massive TB vaccine trial could save millions
Vaccine OngoingThis large study tests an experimental vaccine called M72/AS01E-4 to see if it can prevent tuberculosis (TB) in teens and adults. About 20,000 people will receive either the vaccine or a placebo. The goal is to find a safe and effective way to stop TB, a serious lung infection.
Phase 3 • Sponsor: Gates Medical Research Institute • Aim: Vaccine
Last updated Aug 30, 2026 00:00 UTC
-
Could vitamin B3 help beat TB? new trial launches
Disease control PausedThis phase 2 trial tests whether adding nicotinamide (a form of vitamin B3) to a standard three-drug regimen can safely and effectively treat drug-susceptible pulmonary tuberculosis. About 165 adults with newly diagnosed TB will receive one of two doses of nicotinamide plus the s…
Phase 2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC